Technical Analysis for CRY - CryoLife, Inc.

Grade Last Price % Change Price Change
grade D 28.11 -4.58% -1.35
CRY closed down 4.58 percent on Friday, March 22, 2019, on approximately normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CRY trend table...

Date Alert Name Type % Chg
Mar 22 Fell Below 20 DMA Bearish 0.00%
Mar 22 Fell Below 50 DMA Bearish 0.00%
Mar 22 180 Bearish Setup Bearish Swing Setup 0.00%
Mar 22 Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
Mar 22 BB Squeeze Ended Range Expansion 0.00%
Mar 22 Below Lower BB Weakness 0.00%
Mar 22 Lower Bollinger Band Touch Weakness 0.00%
Mar 21 50 DMA Support Bullish -4.58%
Mar 21 Crossed Above 20 DMA Bullish -4.58%
Mar 21 180 Bullish Setup Bullish Swing Setup -4.58%

Older signals for CRY ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

CryoLife, Inc. preserves and distributes human tissues for transplantation in the United States and internationally. The company also develops, manufactures, and commercializes medical devices for cardiac and vascular applications. It distributes CryoValve SG pulmonary heart valves and CryoPatch SG pulmonary cardiac patch tissues that are processed using CryoLife's proprietary SynerGraft technology; and vascular tissues comprising CryoVein and CryoArtery to treat various vascular reconstructions, such as peripheral bypass, hemodialysis access, and aortic infections. The company also distributes surgical sealants and hemostats, including BioGlue Surgical Adhesive, an adjunct to sutures and staples for use in adult patients in open surgical repair of vessels, as well as in repair of cardiac, vascular, pulmonary, and additional soft tissues. In addition, its surgical sealants and hemostats comprise BioFoam Surgical Matrix for use as an adjunct in the sealing of abdominal parenchymal tissues, when cessation of bleeding by ligature or conventional methods is ineffective or impractical; PerClot, an absorbable powdered hemostat agent used in surgery; and revascularization technologies, which include transmyocardial revascularization system for treating patients with stable angina that is not responsive to conventional therapy. CryoLife, through its subsidiary Cardiogenesis Corporation, specializes in the treatment of coronary artery disease for severe angina using a laser console system and single use, fiber-optic handpieces to perform a surgical procedure known as Transmyocardial Revascularization. The company, through its subsidiary, Hemosphere, Inc., markets HeRO Graft, a solution for end-stage renal disease in certain hemodialysis patients. CryoLife distributes its products through field service representatives, cardiac specialists, direct field representatives, and independent distributors. The company was founded in 1984 and is headquartered in Kennesaw, Georgia.
Medicine Laser Surgery Circulatory System End Stage Renal Disease Hemodialysis Transplantation Bypass Cardiovascular System Coronary Artery Disease Vascular Surgery A Solution Treatment Of Coronary Artery Disease
Is CRY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 36.05
52 Week Low 19.05
Average Volume 190,318
200-Day Moving Average 30.1513
50-Day Moving Average 28.7112
20-Day Moving Average 29.3055
10-Day Moving Average 29.255
Average True Range 1.0705
ADX 12.65
+DI 15.1343
-DI 23.8982
Chandelier Exit (Long, 3 ATRs ) 27.0585
Chandelier Exit (Short, 3 ATRs ) 31.2215
Upper Bollinger Band 30.2055
Lower Bollinger Band 28.4055
Percent B (%b) -0.16
BandWidth 6.142192
MACD Line 0.0489
MACD Signal Line 0.1768
MACD Histogram -0.1279
Fundamentals Value
Market Cap 940.17 Million
Num Shares 33.4 Million
EPS 0.33
Price-to-Earnings (P/E) Ratio 85.18
Price-to-Sales 3.65
Price-to-Book 3.05
PEG Ratio 1.59
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 30.30
Resistance 3 (R3) 30.54 30.04 29.94
Resistance 2 (R2) 30.04 29.49 29.93 29.81
Resistance 1 (R1) 29.08 29.14 28.83 28.84 29.69
Pivot Point 28.58 28.58 28.46 28.47 28.58
Support 1 (S1) 27.62 28.03 27.37 27.38 26.53
Support 2 (S2) 27.12 27.68 27.01 26.41
Support 3 (S3) 26.16 27.12 26.29
Support 4 (S4) 25.92